Fernando Ariza

@IntervenNephMx @bernardo_moguel @Alexgr23 @Omar_SnchezV @ASDINNews @IMINmx @sengndi @SLANH_ @MarkOO7S @brendacfl @dra_miliflores Excelente estructura, nos mantenemos atento y esperamos aprender de la experiencia a medida que se vaya consolidando.

La nefrología del futuro 🩺🚀 se construye con equipo, innovación, formación continua y una visión multidisciplinaria centrada en el paciente. Hoy nace una nueva generación de liderazgo en México 🇲🇽: Grupo NefroIntervención México, que integra a nefrólogos intervencionistas, nefrólogos, personal de enfermería, radiólogos, cirujanos vasculares y todas las especialidades comprometidas con el acceso vascular y peritoneal para la terapia renal y el cuidado integral del paciente renal. Queremos invitar a las nuevas voces de la nefrología mexicana 🇲🇽 a formar parte de este movimiento académico y clínico que busca transformar la práctica de la nefrología intervencionista en nuestro país. Este espacio está diseñado para: 🔹 Impulsar el aprendizaje práctico y la innovación. 🔹 Fortalecer la formación en procedimientos intervencionistas y POCUS. 🔹 Crear redes nacionales e internacionales de colaboración 🌎 🔹 Integrar la experiencia de enfermería especializada como pieza fundamental del éxito clínico. 🔹 Desarrollar investigación, docencia y liderazgo joven 📚 🔹 Promover una atención más segura, eficiente y humana para nuestros pacientes ❤️ Creemos en una nefrología moderna, dinámica y colaborativa 🤝, donde cada profesional aporta valor y donde las nuevas generaciones tienen la oportunidad de liderar el cambio. Si eres un nefrólogo joven, nefrólogo no tan joven o nefrólogo intervencionista con pasión por aprender, enseñar, innovar y construir comunidad, este proyecto también es tuyo. México necesita una nueva visión de la nefrología intervencionista. Y esa visión comienza contigo. ✨ Te invitamos a sumarte, participar y crecer junto a una comunidad que busca hacer historia en la nefrología mexicana 🇲🇽 ¿Estás interesado? Regístrate aquí: ⬇️🔗 tinyurl.com/NefroIntervenc…

En hemodiálisis, añadir 1 vez cada 2 semanas el cartucho dé hemoadsorción Jafron HA130, comparado a no hacerlo; ↓23% riesgo de morir en seguimiento de 39 meses. Mayor protección en los que tenía >3 años en hemodiálisis Ensayo clínico Nature Commun 2026 doi.org/10.1038/s41467…

Interesante observar todos los beneficios que el ultrasonido con sus diferentes modalidades puede ofrecer durante el abordaje de la lesión renal aguda CKJ 2026 academic.oup.com/ckj/advance-ar…

@IhabFathiSulima Acromegaly, GH overproduction

What is the Diagnosis?

#Nurse, #nursepractitioner , #hospitalist , #hospitalmedicine Well, well, how should we digest the results of this review of 19 studies by the Cochrane Collarboration : No difference for care provided by MD's or RN's, not even NP's or PA's . Let's pack our bags

@adrianenrique25 @NephroP Outstanding!!

Interesting #echofirst image 🔗 drsvenkatesan.com/tag/rare-echo-… #POCUS #FOAMed

Sunday morning quiz Which blood component has highest sensitizong event when given to kidney transplant recipients?🩸🩸 Is it A. PACKED RED BLOOD CELLS B. Whole blood C. Leucodepleted PCV D. Platelets ??? Platelets have upto 10* higher HLA expression 🩸🩸 Remember this next time you order SdP for ur patients

@IhabFathiSulima Onychomicosis

What is the diagnosis?

Our recent online publication in @JACCJournals is relevant for clinicians because it advances a distinct, mechanistically targeted paradigm for acute decompensated heart failure (ADHF): mechanical preload regulation rather than further pharmacologic escalation. In the multicenter, prospective VENUS-HF early feasibility experience (n=60), the next-generation preCARDIA system, designed to intermittently regulate superior vena cava (SVC) flow (roughly ~30% of venous return), was deployed and removed successfully in 100% of treated patients, with 98.3% freedom from device/procedure-related major adverse events, supporting a credible safety and real-world technical feasibility signal across diverse operators and sites. By design, SVC-based preload reduction aims to lower right- and left-sided filling pressures without the abrupt hypotension risk seen with inferior vena cava occlusion, and the study’s physiologic results align with that premise: among patients treated for approximately 24 hours, right atrial pressure and pulmonary capillary wedge pressure fell substantially (with paired reductions persisting shortly after device removal), while urine output and net fluid output increased during support, suggesting a potentially meaningful lever on venous congestion/cardiorenal physiology in a population already receiving high-dose diuretics. Taken together, we propose systems like the preCARDIA approach as a scalable hemodynamic unloading platform with small-profile iterations (14F to 10F) and reproducible deployment that could fill a long-standing innovation gap between diuretic-centric care (often limited by diuretic resistance and renal dysfunction) and more invasive or mixed-evidence decongestive strategies (such as ultrafiltration), while providing the rationale and design foundation for larger trials to determine whether targeted mechanical preload reduction can translate physiologic unloading into improved clinical outcomes such as faster, more complete decongestion and fewer rehospitalizations. Check out the paper here: doi.org/10.1016/j.jchf…

@IhabFathiSulima Fixed drug reaction

No trauma or Injury. What type of Drug Reaction?

What is the diagnosis?

@BusingyeEmmanu1 @IhabFathiSulima This is the most appropriate general description !

@IhabFathiSulima Cholinergic toxidrome

@IhabFathiSulima Organophosphate poisoning maybe

Thank you for highlighting this mechanism

@IhabFathiSulima Well, this pt already had a toe amputation which hints at DM foot => Osteo => amputation. Ulcer is chronic and w well-demarcated borders => arterial / PVD . Associated cellulitis through ulcer . Shallow ulcers from edema/cellulitis.

What is the description or diagnosis?

🚨 BIG ANNOUNCEMENT! Introducing AI-Assisted Nephrology Guidelines – your new companion for kidney care! 💥 Speak to major guidelines in plain English, no web searches needed. 1/3 ukidney.com/guidelines

This is such a good resource both for professionals and the public ; had not known of it in the past ; VERY GOOD JOB and THANKS !

@NephRodby @GlassockJ We all have seen this , and in my very first encounters strggled , but now so much more comfortable specially w Cystatin C to give the good news and no need for Rx’s

@GlassockJ No supplements! Just giant muscles. I get one of these consults a year. When I walked in the room I had to chuckle, he was massive. The highest non ckd creatinine I have seen. Always nice to give good news!

With permission, a 48 year old. Creatinine has been 1.5 to 1.9 for 5 years. Urine normal. BP normal.

@JonathanNefro Impresionante !

Con enfermedad renal crónica, tener aislamiento social se asoció a ↑20% el riesgo de muerte, viven ~2 años menos Hipótesis: acceso limitado a sistema de salud, depresión, menos adherencia a tratamientos Kidney Medicine 2025 10.1016/j.xkme.2025.101148